Stocks Hitting 52-Week Lows

AstraZeneca plc (ADR) AZN

shares touched a new 52-week low of $28.21. AstraZeneca shares have tumbled 19.68 percent over the past 52 weeks, while the S&P 500 index has declined 3.98 percent in the same period.

Gain Capital Holdings IncGCAP

shares touched a new 52-week low of $6.19. Raymond James downgraded GAIN Capital Holdings from Outperform to Market Perform.

Pre-IPO Offer: Get A Piece Of A Nearly $5T Global Opportunity By Joining BOXABL As An Early Shareholder At Just $0.80/Share

Massive Demand & Disruptive Potential – Boxabl has received interest for over 190,000 homes, positioning itself as a major disruptor in the housing market.
Revolutionary Manufacturing Approach – Inspired by Henry Ford’s assembly line, Boxabl’s foldable tiny homes are designed for high-efficiency production, making homeownership more accessible.
Affordable Investment Opportunity – With homes priced at $60,000, Boxabl is raising $1 billion to scale production, offering investors a chance to own a stake in its growth.

Share Price: $0.80

Min. Investment: $1,000

Valuation: $3.5B

Osiris Therapeutics, Inc. OSIR

shares reached a new 52-week low of $4.09. Osiris Therapeutics shares have dropped 71.81 percent over the past 52 weeks, while the S&P 500 index has slipped 3.98 percent in the same period.

QLT Inc. (USA) QLTI

shares fell 2.90 percent to touch a new 52-week low of $2.17. QLT shares have declined 44.14 percent over the past 52 weeks, while the S&P 500 index has slipped 3.98 percent in the same period.